EndoQuest Robotics

Enabling Endoluminal and Single-Incision Surgery

Houston, United States · Founded 2017 · $84.0M raised

Headquarters
Houston, Texas
Employees
51–200
Founded
2017
Business Model
B2B
Total Funding
$84.0M
Last Round
$42.0M Series DJul 2025
Rounds
2

About

EndoQuest Robotics is a Houston, Texas-based medical robotics company founded in 2017 that is developing the world's first flexible robotic surgery system for endoluminal and single-incision procedures. The system enables surgery through the body's natural orifices (mouth and anus) or a transumbilical incision, eliminating the need for external incisions required by conventional laparoscopic or robotic surgery. The company has raised over $232 million across six funding rounds, including a Series D-2 round in 2025 co-led by Crescent Enterprises and Dr. Fred Moll.

Summary

EndoQuest Robotics is a Biotech company based in Houston, United States, founded in 2017. It has raised $84.0M in total across 2 rounds, most recently a $42.0M Series D round in Jul 2025. Investors include Crescent Enterprises, Fred Moll and CE Ventures.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series DSeries DJul 2025
$42.0M

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies